文献速递儿科与产科急症

分娩时硬膜外镇痛与子代孤独症谱系障碍的关联

Association of Epidural Analgesia During Labor and Delivery With Autism Spectrum Disorder in Offspring.
PubMed 文献 · JAMA · 2021-01-01
一句话结论大型回顾性队列显示,分娩时硬膜外镇痛与子代孤独症谱系障碍风险仅有小幅相关,且可能由残余混杂导致,不支持强因果关联。

该研究基于加拿大不列颠哥伦比亚省2000–2014年出生的388 254名足月单胎儿童,排除死胎和剖宫产,比较暴露与未暴露于分娩硬膜外镇痛的子代孤独症谱系障碍(ASD)临床诊断风险。暴露组ASD发生率1.53%,未暴露组1.26%,绝对风险差0.28%(95%CI 0.19%-0.36%);完全校正Cox模型HR 1.09(95%CI 1.00-1.15),但同胞匹配条件logistic回归完全校正HR 1.07(95%CI 0.87-1.30)无统计学意义。作者认为存在残余混杂可能,结果不支持强关联。

要点

  • 在388 254名足月单胎儿童中,暴露于分娩硬膜外镇痛者ASD诊断率为1.53%,未暴露者为1.26%,绝对风险差仅0.28%(95%CI 0.19%-0.36%)。
  • 完全校正Cox模型显示硬膜外镇痛与ASD的HR为1.09(95%CI 1.00-1.15),刚达到统计学显著性阈值。
  • 在≥2次分娩且子代ASD状态不一致的女性中进行同胞匹配条件logistic回归,完全校正HR为1.07(95%CI 0.87-1.30),无统计学显著关联。
  • 作者结论:可能存在残余混杂解释该结果,这些发现不支持分娩硬膜外镇痛与子代ASD之间存在强关联。

适用人群与场景

  • 排除:死胎和剖宫产分娩者。
  • 场景:基于人群的回顾性队列,非急诊/ICU床旁干预研究,适用于产房分娩镇痛决策的流行病学参考。

诊断标准与关键阈值

  • ASD诊断标准:由受过ASD评估专业训练的儿科医生、精神科医生和心理学家做出临床诊断,数据来自不列颠哥伦比亚省孤独症评估网络和省教育部。
  • 原文未提及硬膜外镇痛的启动/停止阈值或具体评分界值。

处置流程与药物剂量

  • 原文未提及硬膜外镇痛的具体药物、剂量、给药途径、频次或目标值。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:基于人群的回顾性队列研究,单省(加拿大不列颠哥伦比亚省),样本量388 254名儿童(49.8%女性;平均胎龄39.2周[SD 1.2];平均随访9.05年[SD 4.3])。
  • 暴露与对照:分娩时使用硬膜外镇痛(111 480次分娩,94 157名女性) vs 未使用(276 774次分娩,192 510名女性)。
  • 主要终点:ASD临床诊断。暴露组1710/111 480(1.53%)诊断ASD,未暴露组3482/276 774(1.26%)诊断ASD;绝对风险差0.28%(95%CI 0.19%-0.36%)。
  • 效应量:未校正HR 1.32(95%CI 1.24-1.40);完全校正HR 1.09(95%CI 1.00-1.15)。
  • 关键次要分析:同胞匹配条件logistic回归(≥2次分娩且子代ASD状态不一致的女性)完全校正HR 1.07(95%CI 0.87-1.30),无统计学显著性。
  • 不良事件:原文未提及。

证据类型、等级与局限

  • 证据类型:基于人群的回顾性队列研究。
  • 证据等级/推荐强度:原文未提及。
  • 局限:回顾性设计、单中心/单省数据、可能存在残余混杂(作者明确指出)、暴露组与未暴露组基线特征可能不同(虽经多变量校正)、同胞匹配分析样本量较小导致置信区间宽。

对床旁实践的改变

  • 该研究不支持因担心子代ASD而改变分娩硬膜外镇痛的临床实践;绝对风险差仅0.28%,且同胞匹配分析无显著关联,残余混杂可能解释主要结果。
  • 适用人群:足月单胎、非剖宫产分娩的产妇;不适用于早产、多胎、剖宫产或死胎情况。
  • 常见陷阱:不应将未校正HR 1.32或完全校正HR 1.09(刚达显著性)解读为强因果证据;需注意作者明确提示残余混杂可能。

指南或共识出处

  • 原文未提及指南或共识名称;研究发表于JAMA。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

IMPORTANCE: Evidence from studies investigating the association of epidural analgesia use during labor and delivery with risk of autism spectrum disorder (ASD) in offspring is conflicting.

OBJECTIVE: To assess the association of maternal use of epidural analgesia during labor and delivery with ASD in offspring using a large population-based data set with clinical data on ASD case status.

DESIGN, SETTING, AND PARTICIPANTS: This population-based retrospective cohort study included term singleton children born in British Columbia, Canada, between April 1, 2000, and December 31, 2014. Stillbirths and cesarean deliveries were excluded. Clinical ASD diagnostic data were obtained from the British Columbia Autism Assessment Network and the British Columbia Ministry of Education. All children were followed up until clinical diagnosis of ASD, death, or the study end date of December 31, 2016.

EXPOSURES: Use of epidural analgesia during labor and delivery.

MAIN OUTCOMES AND MEASURES: A clinical diagnosis of ASD made by pediatricians, psychiatrists, and psychologists with specialty training to assess ASD. Cox proportional hazards models were used to estimate the hazard ratio of epidural analgesia use and ASD. Models were adjusted for maternal sociodemographics; maternal conditions during pregnancy; labor, delivery, and antenatal care characteristics; infant sex; gestational age; and status of small or large for gestational age. A conditional logistic regression model matching women with 2 births or more and discordance in ASD status of the offspring also was performed.

RESULTS: Of the 388 254 children included in the cohort (49.8% female; mean gestational age, 39.2 [SD, 1.2] weeks; mean follow-up, 9.05 [SD, 4.3] years), 5192 were diagnosed with ASD (1.34%) and 111 480 (28.7%) were exposed to epidural analgesia. A diagnosis of ASD was made for 1710 children (1.53%) among the 111 480 deliveries exposed to epidural analgesia (94 157 women) vs a diagnosis of ASD in 3482 children (1.26%) among the 276 774 deliveries not exposed to epidural analgesia (192 510 women) (absolute risk difference, 0.28% [95% CI, 0.19%-0.36%]). The unadjusted hazard ratio was 1.32 (95% CI, 1.24-1.40) and the fully adjusted hazard ratio was 1.09 (95% CI, 1.00-1.15). There was no statistically significant association of epidural analgesia use during labor and delivery with ASD in the within-woman matched conditional logistic regression (839/1659 [50.6%] in the exposed group vs 1905/4587 [41.5%] in the unexposed group; fully adjusted hazard ratio, 1.07 [95% CI, 0.87-1.30]).

CONCLUSIONS AND RELEVANCE: In this population-based study, maternal epidural analgesia use during labor and delivery was associated with a small increase in the risk of autism spectrum disorder in offspring that met the threshold for statistical significance. However, given the likelihood of residual confounding that may account for the results, these findings do not provide strong supporting evidence for this association.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Hanley GE, Bickford C, Ip A, et al. Association of Epidural Analgesia During Labor and Delivery With Autism Spectrum Disorder in Offspring. JAMA. 2021. PMID: 34581736. doi:10.1001/jama.2021.14986

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。